Literature DB >> 20501235

Evidence for a new subclass of calcitonin/ calcitonin gene-related peptide binding site in rat brain.

P M Sexton1, J S McKenzie, F A Mendelsohn.   

Abstract

Binding sites for calcitonin and calcitonin gene-related peptide are widely distributed in the central nervous system. In this study, binding of [(125)I]-alpha-rat calcitonin gene-related peptide and [(125)I]-salmon calcitonin in adjacent sections of rat brain revealed clearly distinct patterns of binding in most regions although in some restricted areas such as parts of the ventral striatum, including the nucleus accumbens, there was some overlap in the patterns of binding. In the primary olfactory cortex, which bound only calcitonin gene-related peptide, salmon calcitonin was very weak in inhibiting the binding of calcitonin gene-related peptide. In the nucleus accumbens, high affinity binding of calcitonin and calcitonin gene-related peptide at their homologous receptors was observed, with affinity constants for calcitonin and calcitonin gene-related peptide of 1.4 x 10(9) M(?1) and 1.2 x 10(9) M(?1) respectively. Cross competition studies in this nucleus demonstrated that salmon calcitonin was able to compete for [(125)I]-rat calcitonin gene-related peptide labelled sites with high affinity, with an affinity constant of 0.8 x 10(9) M(?1). However, rat calcitonin gene-related peptide was less potent in inhibiting the binding of [(125)I]-salmon calcitonin labelled sites with only 28% inhibition at 10(?6)M. Further characterization of the calcitonin sensitive calcitonin gene-related peptide labelled sites demonstrated that a range of calcitonin analogs inhibited the binding of [(125)I]-rat calcitonin gene-related peptide with the same order of potency as the analogs competed for [(125)I]-salmon calcitonin labelled sites. Digital substraction mapping revealed calcitonin-sensitive calcitonin gene-related peptide binding sites over parts of the ventral striatum, including mid-caudal nucleus accumbens and fundus striati; over the lateral border of the lateral bed nucleus of the stria terminalis; part of the central amygdaloid nucleus; the organum vasculosum of the lamina terminalis and area postrema and over the wings of the dorsal raphe. These results demonstrate the existence of a new subtype of calcitonin/calcitonin gene-related peptide binding site, which has high affinity for the two otherwise biochemically distinct peptides.

Entities:  

Year:  1988        PMID: 20501235     DOI: 10.1016/0197-0186(88)90171-4

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  10 in total

1.  Characterization of receptors for calcitonin gene-related peptide and adrenomedullin on the guinea-pig vas deferens.

Authors:  D R Poyner; G M Taylor; A E Tomlinson; A G Richardson; D M Smith
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 2.  Central nervous system binding sites for calcitonin and calcitonin gene-related peptide.

Authors:  P M Sexton
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.

Authors:  Sajedeh Eftekhari; Lars Edvinsson
Journal:  Ther Adv Neurol Disord       Date:  2010-11       Impact factor: 6.570

4.  CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.

Authors:  Lars Edvinsson
Journal:  Br J Clin Pharmacol       Date:  2015-05-19       Impact factor: 4.335

5.  Effects of calcitonin gene-related peptide (CGRP), neurokinin A and neurokinin A (4-10) on the mitogenic response of human peripheral blood mononuclear cells.

Authors:  A Casini; P Geppetti; C A Maggi; C Surrenti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

6.  Calcitonin receptor antibody validation and expression in the rodent brain.

Authors:  Erica R Hendrikse; Tayla A Rees; Zoe Tasma; Christelle Le Foll; Thomas A Lutz; Andrew Siow; Peter J Wookey; Christopher S Walker; Debbie L Hay
Journal:  Cephalalgia       Date:  2022-04-11       Impact factor: 6.075

7.  Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level.

Authors:  Sajedeh Eftekhari; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2011-11-10       Impact factor: 3.288

8.  The effect of intracerebroventricular injection of CGRP on pain behavioral responses and monoamines concentrations in the periaqueductal gray area in rat.

Authors:  Kaveh Rahimi; Javad Sajedianfard; Ali Akbar Owji
Journal:  Iran J Basic Med Sci       Date:  2018-04       Impact factor: 2.699

9.  Calcitonin receptor expression in medullary thyroid carcinoma.

Authors:  Virginia Cappagli; Catarina Soares Potes; Luciana Bueno Ferreira; Catarina Tavares; Catarina Eloy; Rossella Elisei; Manuel Sobrinho-Simões; Peter J Wookey; Paula Soares
Journal:  PeerJ       Date:  2017-09-13       Impact factor: 2.984

10.  Effects of Salmon Calcitonin on the Concentrations of Monoamines in Periaqueductal Gray in Formalin Test

Authors:  Kaveh Rahimi; Javad Sajedianfard; Ali Akbar Owji
Journal:  Balkan Med J       Date:  2019-06-20       Impact factor: 2.021

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.